癌痛在全球范围内是一个普遍存在的问题,据世界卫生组织统计,全世界每年新发癌症患者约900万,其中400万人遭受疼痛折磨,约1/3癌痛患者未能得到应有控制。80％晚期癌症患者以疼痛为主要症状。多年来止痛药应用副作用多,毒麻药易成瘾,止痛效果不理想。我科,自1995年以来,应用北京萌蒂医药有限公司生产的美施康定(硫酸吗啡控释片,Controlled release morphne sulfate MS confin~((R)),LGT)治疗住院癌痛患者48例,现将其临床观察总结如下。 Cancer pain is a common problem on a global scale. According to the statistics of the World Health Organization, about 9 million new cancer patients are diagnosed every year in the world, 4 million of whom suffer from pain, and about 1/3 of cancer patients fail to receive due treatment. control. 80% of patients with advanced cancer have pain as the main symptom. For many years, analgesics have many side effects, narcotic drugs are addictive, and the analgesic effect is not ideal. In our department, since 1995, 48 cases of inpatients suffering from cancer pain have been treated with Methinkine (Controlled release morphine sulfate MS confin~(R)), LGT produced by Beijing Mengti Pharmaceutical Co., Ltd. The clinical observations are summarized below.